Works matching IS 00070963 AND DT 2017 AND VI 176 AND IP 3

Results: 59
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Frequency and predictors of a high clinical response in patients with psoriasis on biological therapy in daily practice: results from the prospective, multicenter Bio CAPTURE cohort.

    Published in:
    British Journal of Dermatology, 2017, v. 176, n. 3, p. 786, doi. 10.1111/bjd.14888
    By:
    • Zweegers, J.;
    • Roosenboom, B.;
    • Kerkhof, P.C.M.;
    • Reek, J.M.P.A.;
    • Otero, M.E.;
    • Atalay, S.;
    • Kuijpers, A.L.A.;
    • Koetsier, M.I.A.;
    • Arnold, W.P.;
    • Berends, M.A.;
    • Weppner ‐ Parren, L.;
    • Bijen, M.;
    • Njoo, M.D.;
    • Mommers, J.M.;
    • Lümig, P.P.M.;
    • Driessen, R.J.B.;
    • Kievit, W.;
    • Jong, E.M.G.J.
    Publication type:
    Article
    14
    15
    16
    17

    News and Notices.

    Published in:
    British Journal of Dermatology, 2017, v. 176, n. 3, p. 837, doi. 10.1111/bjd.15411
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30

    Predictors of perceived stigmatization in patients with psoriasis.

    Published in:
    British Journal of Dermatology, 2017, v. 176, n. 3, p. 687, doi. 10.1111/bjd.14875
    By:
    • BeugEN, S.;
    • MiddENdorp, H.;
    • Ferwerda, M.;
    • Smit, J.V.;
    • ZeeuwEN ‐ FranssEN, M.E.J.;
    • Kroft, E.B.M.;
    • Jong, E.M.G.J.;
    • Donders, A.R.T.;
    • Kerkhof, P.C.M.;
    • Evers, A.W.M.
    Publication type:
    Article
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47

    Safety, complications and patients' acceptance of Mohs micrographic surgery under local anaesthesia: results from the U.K. MAPS (Mohs Acceptance and Patient Safety) Collaboration Group.

    Published in:
    British Journal of Dermatology, 2017, v. 176, n. 3, p. 806, doi. 10.1111/bjd.14843
    By:
    • Hussain, W.;
    • Affleck, A.;
    • Al ‐ Niaimi, F.;
    • Cooper, A.;
    • Craythorne, E.;
    • Fleming, C.;
    • Ghura, V.;
    • Langtry, J.;
    • Lawrence, C.;
    • Loghdey, S.;
    • Naysmith, L.;
    • Oliphant, T.;
    • Rahim, R.;
    • Rice, S.;
    • Sivaramkrishan, M.;
    • Stables, G.;
    • Varma, S.;
    • Mallipeddi, R.
    Publication type:
    Article
    48

    Should tumour necrosis factor antagonist safety information be applied from patients with rheumatoid arthritis to psoriasis? Rates of serious adverse events in the prospective rheumatoid arthritis BIOBADASER and psoriasis BIOBADADERM cohorts.

    Published in:
    British Journal of Dermatology, 2017, v. 176, n. 3, p. 643, doi. 10.1111/bjd.14776
    By:
    • García ‐ Doval, I.;
    • Hernández, M.V.;
    • Vanaclocha, F.;
    • Sellas, A.;
    • Cueva, P.;
    • Montero, D.;
    • Rodríguez, Basilio;
    • Barceló, Mireia;
    • Farietta, Sandra;
    • Montoro, María;
    • González, Ainhoa;
    • Herráez, Elena;
    • Ruíz ‐ Montesino, Mª Dolores;
    • Vargas, Carmen;
    • Pérez ‐ Pampín, Eva;
    • Ortiz, Ana Mª;
    • Tomero, Eva;
    • Sifuentes, Alberto;
    • Antón, Fred;
    • Zea, Antonio
    Publication type:
    Article
    49
    50